Locum Consultant - Late Cancer Treatment Effects Lead
at The Royal Marsden NHS Foundation Trust
Sutton SM2 5PT, England, United Kingdom -
Start Date | Expiry Date | Salary | Posted On | Experience | Skills | Telecommute | Sponsor Visa |
---|---|---|---|---|---|---|---|
Immediate | 19 Feb, 2025 | GBP 139882 Annual | 19 Nov, 2024 | N/A | Good communication skills | No | No |
Required Visa Status:
Citizen | GC |
US Citizen | Student Visa |
H1B | CPT |
OPT | H4 Spouse of H1B |
GC Green Card |
Employment Type:
Full Time | Part Time |
Permanent | Independent - 1099 |
Contract – W2 | C2H Independent |
C2H W2 | Contract – Corp 2 Corp |
Contract to Hire – Corp 2 Corp |
Description:
Late effects are an important cause of long-term mortality but are sub-optimally researched and managed. In the modern treatment era, there is also rapidly emerging a new ‘wave’ of cancer patients treated with novel immunotherapies and targeted therapies achieving high rates of durable response to treatment where little is known about long-term treatment-related late effects. RM, as one of the largest cancer treatment centres in UK, is in a unique position to establish large cohorts of patients with long follow-up. For example, a large existing cohort of women treated for lymphoma at RM/ICR influenced national high risk breast cancer screening. Building on this expertise, the BRC will expand and update cohorts and link with national datasets to explore risks of late effects for multiple treatments. Knowledge of late effects of newer treatments will contribute to earlier diagnosis and improved management of late effects and to new research into future treatments. The BRC also aims to translate late effects incidence risk tables into online late effects risk prediction tools to enable interactive and personalised informed discussion between patients and clinicians on risk of a range of late effects.
The post-holder will focus on late treatment effects for lymphoma and expand the research portfolio to studies addressing treatment effects involving other tumour types. They will work closely with the Theme Lead and Deputy Theme Lead for the BRC Cancer Treatment Effects theme to provide leadership of the emerging portfolio of late effects studies in line with the Theme aims.
The Royal Marsden NHS Foundation Trust is a world-leading cancer centre. Our role is to offer our patients the best cancer care available anywhere in the world, and to continue to make a global contribution to finding better ways of diagnosing and treating cancer. We employ over 3,900 staff in a diverse range of careers including nursing, medical, science, radiography, pharmacy, occupational therapy, finance and administrative services. We have two hospitals – one in Chelsea, London, and one in Sutton, Surrey – as well as a Medical Daycare Unit in Kingston Hospital
At The Royal Marsden, we deal with cancer every day, so we understand how valuable life is. When people entrust their lives to us, they have the right to demand the very best. That’s why the pursuit of excellence lies at the heart of everything we do.
At the heart of the hospital is our dedicated team. We offer a stimulating and dynamic working environment, a wide range of staff benefits and learning and development opportunities. We are looking for employees who aspire to excellence, share our values and can play a crucial role in our on-going achievements.
For further information on this role, please see the attached detailed Job Description and Person Specification
How To Apply:
Incase you would like to apply to this job directly from the source, please click here
Responsibilities:
Please refer the Job description for details
REQUIREMENT SUMMARY
Min:N/AMax:5.0 year(s)
Hospital/Health Care
Pharma / Biotech / Healthcare / Medical / R&D
Health Care
Graduate
Proficient
1
Sutton SM2 5PT, United Kingdom